Brief: Delcath Systems Announces New Drug Application Resubmission For Hepzato Kit
14/02/2023 15:10
Delcath Systems Inc DCTH.O :
* DELCATH SYSTEMS ANNOUNCES NEW DRUG APPLICATION
RESUBMISSION FOR
HEPZATO KIT
* DELCATH SYSTEMS INC - RESUBMISSION IS IN RESPONSE TO A
SEPTEMBER
12, 2013 COMPLETE RESPONSE LETTER (CRL) FROM FDA
* DELCATH SYSTEMS INC - LOOK FORWARD TO RECEIVING FEEDBACK
FROM
FDA REGARDING A PDUFA DATE WITHIN 30 DAY
Source text for Eikon: ID:nPn3l5ryPa
Further company coverage: DCTH.O
Recent news on Delcath Systems
See all newsBrief: Delcath Systems Highlights Clinical Program Presentations At Esmo Congress 2026 And Independent Data On Percutaneous Hepatic Perfusion In Liver-Dominant Metastatic Uveal Melanoma
Brief: Delcath Systems Announces Inducement Grants Under Nasdaq Listing Rule
Delcath Systems Inc reports results for the quarter ended June 30 - Earnings Summary
Delcath Systems Q2 revenue rises, beats estimates
Delcath Systems Inc expected to post a loss of 9 cents a share - Earnings Preview